Contact this trialFirst, we need to learn more about you.
Immunotherapy
PD-1/PD-L1 Inhibitor Therapy Duration for Cancer
Recruiting2 awardsPhase 3
Pittsburgh, Pennsylvania
This trial will study whether it is better to stop treatment with PD-1/PD-L1 therapy after one year or continue until disease progression.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.